FeesSafety
Pluang+

CPS Technologies schedules Q3 2026 earnings call for November 4, 2026

Company Fundamentals
26 Oct 2026, 23:15 WIB
GlobeNewsWire
View Source
Neutral
CPS Technologies schedules Q3 2026 earnings call for November 4, 2026

CPS Technologies Corp. announced its third quarter 2026 earnings call will take place on November 4, 2026, at 9:00 A.M. Eastern Time. The call will feature President and CEO Brian Mackey and CFO Chris Fraser discussing the company's financial results for the quarter ending September 26, 2026. CPS Technologies specializes in advanced materials like metal matrix composites for high-performance applications across various industries including transportation, energy, and aerospace. Investors and interested parties can join the call using the provided dial-in number and passcode.

CPS Technologies' upcoming Q3 earnings call is scheduled for November 4, 2026. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Oct 27, 2026 03:11 WIB: out of 83 priced US stocks, 39 rose and 43 fell. Notable movers include Newmont Corporation (NEM) at USD 109.00 with a 1-day change of -4.48% and 100% buy order activity, Almonty Industries Inc. (ALM) at USD 9.25 with a 4.46% rise, and Johnson Controls International PLC (JCI) at USD 144.59 with a -4.26% change. The most notable figure is NEM's 100% buy order activity on Pluang.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App